Thomas A. Zalewski
Chief Legal Officer & Chief Compliance OfficerMr. Thomas A. Zalewski serves as Chief Legal Officer & Chief Compliance Officer of Aquestive Therapeutics, Inc. from April 2, 2026. Mr. Zalewski joined the Aquestive Therapeutics, Inc. on April 2, 2026. Mr. Zalewski is a Partner at Day Pitney LLP, where he serves as Chair of the firm's Healthcare and Life Sciences practice. He has considerable experience advising life sciences, technology and healthcare companies on a broad range of strategic and commercial matters, including mergers and acquisitions, licensing and intellectual property transactions, corporate governance and regulatory matters. Mr. Zalewski has also served as outside general counsel to emerging and middle-market companies and previously served as a senior member of the legal team at Dendrite International, Inc. (now IQVIA), a publicly held provider of technology, sales and marketing solutions to the global life sciences industry. He received a B.A. from Rutgers University and a J.D. from Seton Hall University School of Law.
Positions
- Company NameAquestive Therapeutics, Inc.Stock CodeAQSTPositionChief Legal Officer & Chief Compliance OfficerColleagues
- DBDaniel BarberCEO, President & Director
- GBGregory Bailey BrownIndependent Chairman of the Board
- AEA. Ernest TothSenior VP & CFO
- LJLori J. BraenderCorporate Secretary
- CJCassie JungChief Operating Officer
- JSJohn Shannon CochranIndependent Vice Chairman of the Board
- TETimothy E. MorrisIndependent Director
- JKJulie KropIndependent Director
